Literature DB >> 22796447

Expression and characterization of 15N-labeled human C-reactive protein in Escherichia coli and Pichia pastoris for use in isotope-dilution mass spectrometry.

Eric L Kilpatrick1, Wei-Li Liao, Johanna E Camara, Illarion V Turko, David M Bunk.   

Abstract

Levels of C-reactive protein (CRP) in serum are correlated with inflammation and disease in humans. A higher level quantitative method, such as isotope-dilution mass spectrometry (ID-MS) is needed to compare and standardize the many commercial CRP assays. We compare the expression and purification of (15)N-CRP from Escherichia coli and Pichia pastoris and show that the protein isolated from P. pastoris has native pentameric structure along with high isotopic enrichment as shown by software developed specifically for this purpose. When this preparation was mixed in various ratios with unlabeled CRP and tryptic peptides of the mixtures were analyzed by LC-MS/MS, the ratios of heavy and light peaks were tightly correlated with input amounts of each protein. In this report we confirm the suitability of (15)N-rCRP as an internal standard in ID-MS. Standardization of CRP assays should help validate the relationship between CRP and human health. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22796447     DOI: 10.1016/j.pep.2012.06.019

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  13 in total

1.  Optimizing High-Resolution Mass Spectrometry for the Identification of Low-Abundance Post-Translational Modifications of Intact Proteins.

Authors:  Lisa E Kilpatrick; Eric L Kilpatrick
Journal:  J Proteome Res       Date:  2017-08-08       Impact factor: 4.466

2.  Identification of Novel N-Glycosylation Sites at Noncanonical Protein Consensus Motifs.

Authors:  Mark S Lowenthal; Kiersta S Davis; Trina Formolo; Lisa E Kilpatrick; Karen W Phinney
Journal:  J Proteome Res       Date:  2016-06-14       Impact factor: 4.466

3.  Optimization of the secretory expression of recombinant human C-reactive protein in Pichia pastoris.

Authors:  Junming Li; Chengming Sun; Lei Chen; Lihui Sun; Lijun Duan; Qing Zheng; Xuejun Hu
Journal:  3 Biotech       Date:  2017-08-29       Impact factor: 2.406

4.  Probing the phosphocholine-binding site of human C-reactive protein by site-directed mutagenesis.

Authors:  A Agrawal; Y Xu; D Ansardi; K J Macon; J E Volanakis
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

5.  Biophysical characterization and structure of the Fab fragment from the NIST reference antibody, RM 8671.

Authors:  Ioannis Karageorgos; Elyssia S Gallagher; Connor Galvin; D Travis Gallagher; Jeffrey W Hudgens
Journal:  Biologicals       Date:  2017-09-29       Impact factor: 1.856

6.  Quantification of Borrelia burgdorferi Membrane Proteins in Human Serum: A New Concept for Detection of Bacterial Infection.

Authors:  Crystal S F Cheung; Kyle W Anderson; Kenia Y Villatoro Benitez; Mark J Soloski; John N Aucott; Karen W Phinney; Illarion V Turko
Journal:  Anal Chem       Date:  2015-11-04       Impact factor: 6.986

7.  Heterologous recombinant expression of non-originator NISTmAb.

Authors:  Lila Kashi; Katharina Yandrofski; Renae J Preston; Luke W Arbogast; John P Giddens; John P Marino; John E Schiel; Zvi Kelman
Journal:  MAbs       Date:  2018-07-30       Impact factor: 5.857

8.  Evaluation of INSTAND e.V.'s external quality assessment for C-reactive protein and procalcitonin.

Authors:  Nathalie Wojtalewicz; Ingo Schellenberg; Klaus-Peter Hunfeld
Journal:  PLoS One       Date:  2019-08-16       Impact factor: 3.240

Review 9.  Mass spectrometry-based approaches to targeted quantitative proteomics in cardiovascular disease.

Authors:  Clementina Mesaros; Ian A Blair
Journal:  Clin Proteomics       Date:  2016-10-05       Impact factor: 3.988

10.  Development of an LC-MS/MS peptide mapping protocol for the NISTmAb.

Authors:  Trina Mouchahoir; John E Schiel
Journal:  Anal Bioanal Chem       Date:  2018-02-07       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.